These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30101940)

  • 1. Is Severe and Long-lasting Linezolid-induced Optic Neuropathy Reversible?
    Lee S; Kang BH; Ryu WY; Um SJ; Roh MS; Son C
    Intern Med; 2018 Dec; 57(24):3611-3613. PubMed ID: 30101940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral neuropathy in a diabetic child treated with linezolid for multidrug-resistant tuberculosis: a case report and review of the literature.
    Swaminathan A; du Cros P; Seddon JA; Mirgayosieva S; Asladdin R; Dusmatova Z
    BMC Infect Dis; 2017 Jun; 17(1):417. PubMed ID: 28606115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linezolid Induced Reversible Peripheral Neuropathy.
    Vishnu VY; Modi M; Goyal MK; Lal V
    Am J Ther; 2016; 23(6):e1839-e1841. PubMed ID: 26741956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linezolid-Associated Optic Neuropathy in Drug-Resistant Tuberculosis Patients in Mumbai, India.
    Mehta S; Das M; Laxmeshwar C; Jonckheere S; Thi SS; Isaakidis P
    PLoS One; 2016; 11(9):e0162138. PubMed ID: 27611434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Severe linezolid-induced toxic optic neuropathy].
    Xerri O; Lemaire B; Nasser G; Rousseau-Huvey B; Labetoulle M; Rousseau A
    J Fr Ophtalmol; 2015 Mar; 38(3):e55-8. PubMed ID: 25637235
    [No Abstract]   [Full Text] [Related]  

  • 6. Optic neuropathy secondary to Linezolid for multidrug-resistant mycobacterial spinal tuberculosis.
    Agrawal R; Addison P; Saihan Z; Pefkianaki M; Pavesio C
    Ocul Immunol Inflamm; 2015 Feb; 23(1):90-2. PubMed ID: 24432953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reactions due to linezolid in the programmatic management of drug-resistant tuberculosis in India: A retrospective multicenter study.
    Mishra G; Alffenaar JW; Munje R; Khateeb S
    Indian J Tuberc; 2024; 71 Suppl 1():S101-S109. PubMed ID: 39067941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France.
    Jaspard M; Butel N; El Helali N; Marigot-Outtandy D; Guillot H; Peytavin G; Veziris N; Bodaghi B; Flandre P; Petitjean G; Caumes E; Pourcher V
    Emerg Infect Dis; 2020 Aug; 26(8):1792-1800. PubMed ID: 32687026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linezolid induced toxic optic neuropathy in drug resistant tuberculosis-A case series.
    Vallabhaneni S; Mendonca TM; Nayak RR; Kamath G; Kamath A
    Indian J Tuberc; 2024; 71 Suppl 1():S5-S9. PubMed ID: 39067955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peripheral and optic neuropathy associated to linezolod in multidrug resistant Mycobacterium bovis infection].
    Hernández Prats C; Llinares Tello F; Climent Grana E; Fernández Aracil C
    Med Clin (Barc); 2005 May; 124(20):797-8. PubMed ID: 15927111
    [No Abstract]   [Full Text] [Related]  

  • 11. Proposed Linezolid Dosing Strategies to Minimize Adverse Events for Treatment of Extensively Drug-Resistant Tuberculosis.
    Imperial MZ; Nedelman JR; Conradie F; Savic RM
    Clin Infect Dis; 2022 May; 74(10):1736-1747. PubMed ID: 34604901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linezolid-induced optic neuropathy in XDR pulmonary TB: A case series.
    Srivastava A; Kshetrimayum S; Gupta SK; Kant S
    Indian J Tuberc; 2017 Apr; 64(2):129-133. PubMed ID: 28410695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linezolid-induced optic neuropathy.
    Saijo T; Hayashi K; Yamada H; Wakakura M
    Am J Ophthalmol; 2005 Jun; 139(6):1114-6. PubMed ID: 15953450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible neuropathy in extremely-drug resistant tuberculosis: An unfortunate clinical conundrum.
    Saroha D; Garg D; Singh AK; Dhamija RK
    Indian J Tuberc; 2020 Jul; 67(3):389-392. PubMed ID: 32825876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linezolid in the treatment of multidrug-resistant tuberculosis.
    Schecter GF; Scott C; True L; Raftery A; Flood J; Mase S
    Clin Infect Dis; 2010 Jan; 50(1):49-55. PubMed ID: 19947856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06.
    Anger HA; Dworkin F; Sharma S; Munsiff SS; Nilsen DM; Ahuja SD
    J Antimicrob Chemother; 2010 Apr; 65(4):775-83. PubMed ID: 20150181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases.
    von der Lippe B; Sandven P; Brubakk O
    J Infect; 2006 Feb; 52(2):92-6. PubMed ID: 15907341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    Koh WJ; Kwon OJ; Gwak H; Chung JW; Cho SN; Kim WS; Shim TS
    J Antimicrob Chemother; 2009 Aug; 64(2):388-91. PubMed ID: 19468028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial.
    Lee M; Mok J; Kim DK; Shim TS; Koh WJ; Jeon D; Lee T; Lee SH; Kim JS; Park JS; Lee JY; Kim SY; Lee JH; Jo KW; Jhun BW; Kang YA; Ahn JH; Kim CK; Shin S; Song T; Shin SJ; Kim YR; Ahn H; Hahn S; Won HJ; Jang JY; Cho SN; Yim JJ
    Trials; 2019 Jan; 20(1):57. PubMed ID: 30651149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
    Park IN; Hong SB; Oh YM; Kim MN; Lim CM; Lee SD; Koh Y; Kim WS; Kim DS; Kim WD; Shim TS
    J Antimicrob Chemother; 2006 Sep; 58(3):701-4. PubMed ID: 16857689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.